Cargando…
Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability
To improve the specificity and penetration of anticancer peptides against tumors, in this study, we examined the effects of co-administration of the membrane-active peptide HPRP-A1 and the tumor homing/penetrating peptide iRGD. iRGD peptide is widely recognized as an efficient cell membrane penetrat...
Autores principales: | Hu, Cuihua, Chen, Xiaolong, Huang, Yibing, Chen, Yuxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797073/ https://www.ncbi.nlm.nih.gov/pubmed/29396568 http://dx.doi.org/10.1038/s41598-018-20715-4 |
Ejemplares similares
-
Coadministration of kla peptide with HPRP-A1 to enhance anticancer activity
por: Hao, Wenjing, et al.
Publicado: (2019) -
iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery
por: Kang, Sujin, et al.
Publicado: (2020) -
Anticancer activity of Pseudomonas aeruginosa derived peptide with iRGD in colon cancer therapy
por: Yaghoubi, Atieh, et al.
Publicado: (2023) -
Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD
por: Fadeev, Roman, et al.
Publicado: (2019) -
In vitro Characterization of the Rapid Cytotoxicity of Anticancer Peptide HPRP-A2 through Membrane Destruction and Intracellular Mechanism against Gastric Cancer Cell Lines
por: Zhao, Jing, et al.
Publicado: (2015)